Coherus BioSciences, Inc. - COM (CHRS)

Historical Portfolio Holders from Q4 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
78.6 M
Holdings value Q1 2024
$188 M
Value change Q1 2024
-$8.88 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
128
Number of buys Q1 2024
55
Number of sells Q1 2024
-92
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
19249H103
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 78.6 M $188 M -$8.88 M $2.39 128
2023 Q4 79.1 M $264 M -$40.1 M $3.33 151
2023 Q3 91.4 M $342 M +$14.5 M $3.74 165
2023 Q2 86.6 M $370 M +$30.6 M $4.27 158
2023 Q1 78.1 M $534 M -$2.03 M $6.84 165
2022 Q4 78.3 M $620 M +$4.1 M $7.92 159
2022 Q3 76.6 M $736 M -$15.2 M $9.61 163
2022 Q2 78 M $566 M +$18 M $7.24 166
2022 Q1 75.4 M $972 M -$15 M $12.91 167
2021 Q4 75.8 M $1.21 B +$10.3 M $15.96 187
2021 Q3 74.8 M $1.2 B -$20.6 M $16.07 180
2021 Q2 76.9 M $1.06 B -$38.2 M $13.83 181
2021 Q1 79.4 M $1.16 B -$125 M $14.61 200
2020 Q4 86.1 M $1.5 B +$7.55 M $17.38 187
2020 Q3 87.6 M $1.61 B -$15.5 M $18.34 197
2020 Q2 86.5 M $1.54 B +$223 M $17.86 184
2020 Q1 69.9 M $1.13 B +$20.8 M $16.22 180
2019 Q4 72.2 M $1.3 B +$58.2 M $18.00 181
2019 Q3 68.7 M $1.39 B +$50.2 M $20.26 161
2019 Q2 66.2 M $1.46 B +$24.7 M $22.10 139
2019 Q1 64.6 M $881 M +$50.9 M $13.64 112
2018 Q4 63.3 M $573 M -$18 M $9.05 105
2018 Q3 57 M $941 M +$38.9 M $16.50 103
2018 Q2 61.9 M $866 M +$96.2 M $14.00 112
2018 Q1 55.3 M $611 M +$32.9 M $11.05 102
2017 Q4 49.1 M $432 M +$14.8 M $8.80 92
2017 Q3 46.9 M $626 M +$87.7 M $13.35 90
2017 Q2 39.6 M $569 M +$24.4 M $14.35 103
2017 Q1 37.3 M $788 M +$211 M $21.15 110
2016 Q4 29.6 M $832 M +$50.9 M $28.15 120
2016 Q3 27.8 M $743 M +$77.9 M $26.78 115
2016 Q2 25.3 M $428 M +$112 M $16.89 84
2016 Q1 18 M $381 M +$29.1 M $21.23 72
2015 Q4 16.6 M $382 M +$9.73 M $22.96 76
2015 Q3 14.5 M $291 M +$15.6 M $20.04 74
2015 Q2 14.9 M $431 M +$228 M $28.90 71
2015 Q1 5.71 M $174 M -$28.1 M $30.58 48
2014 Q4 8.29 M $132 M +$132 M $16.32 35